Novax Medicine (NVAXnewfreeslotmachineswithfreespins.US) U.S. stocks continue to rise 9.9newfreeslotmachineswithfreespins.91%, at US$9.76, the stock surged more than 98% last Friday, its largest one-day gain since listing. On the news front, Novavax Pharmaceuticals announced last Friday that it had reached an agreement with French pharmaceutical giant Sanofi.newfreeslotmachineswithfreespinsA multi-billion-dollar cooperation agreement was signed. According to the agreement, the two parties will jointly commercialize Novavacs Pharma's COVID-19 vaccine starting next year and jointly develop a combination vaccine against coronavirus and influenza. According to S3 Partners LLC, Friday's surge in stock prices has caused a huge impact on short sellers.newfreeslotmachineswithfreespinsThere was a paper loss of approximately $255 million. Bank of America raised its target price for the stock to $12 from $4 and upgraded its rating to "neutral" from "underperform".
